The CHA2DS2-VASc score is one of the most validated risk tools in atrial fibrillation (AF) [1], and remains a simple and practical clinical score to aid decision-making. However, it has limitations in predicting the absolute stroke risk and its ability for identifying patients at risk of thromboembolism is modest.
